
Work Here?
Seqera Labs provides software to orchestrate data analysis pipelines in genomics and life sciences. Built on Nextflow, Seqera Tower adds enterprise features for collaboration, monitoring, and deploying pipelines at scale on premises or in the cloud. It differentiates by offering an enterprise-grade runtime layer on top of the open-source Nextflow core, focusing on governance, scalability, and collaboration for pharma, biotech, and genomics teams. The goal is to help researchers accelerate genomic data analysis and drug discovery, enabling faster public health responses and more efficient scientific workflows across large organizations.
Industries
Data & Analytics
Enterprise Software
Biotechnology
Healthcare
Company Size
51-200
Company Stage
Series A
Total Funding
$29.8M
Headquarters
Barcelona, Spain
Founded
2018
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$29.8M
Above
Industry Average
Funded Over
3 Rounds
Industry standards
Health Insurance
Private health insurance
Wellness Program
Mental Health Support
Home Office Stipend
Learning and development budget per year (1,000 USD)
Unlimited Paid Time Off
Flexible Work Hours
Hybrid Work Options
Seqera acquires Tinybio to democratize access to ai-powered bioinformatics.
Seqera has acquired Tinybio, a tech-bio startup specializing in AI-powered bioinformatics tools, to enhance its scientific data analysis platform. The acquisition aims to democratize access to advanced bioinformatics through natural language processing and user-friendly interfaces. Tinybio’s founders, CEO Sasha Dagayev and CTO Vishal Patel, will collaborate with Seqera to advance open-source software and scientific progress. Financial details were not disclosed.
In 2020, Seqera launched Seqera Platform (formerly Nextflow Tower), a centralized command post for Nextflow pipelines.
BARCELONA, Spain, Oct. 20, 2023 (GLOBE NEWSWIRE) -- Seqera, the leading software provider for complex data analysis in the life sciences space, has been confirmed as the official High Performance Computing Supplier for Alinghi Red Bull Racing at the 37 America's Cup.
Researchers tackling biggest health crises say open-source collaboration is now ‘fundamental’75% of 500 global researchers are collaborating on health research projects including oncology and infectious disease monitoringLONDON, June 2023: As the UK Health Security Agency announces a plan for a “genomics transformation”, new data has revealed that nearly three quarters (72%) of research scientists believe open-source collaboration and workflow management is now “fundamental” to the work they do.The data published by Seqera Labs, the leading provider of secure data orchestration software, brings together the views of 500 researchers and scientists who use open-source scientific workflow platforms for their work. Such systems are used by researchers to standardize the way data is analysed, reduce duplication and provide the infrastructure for high level projects both within their organizations and externally in genomics, metagenomics, and transcriptomics.The study found that open-source workflow platforms are currently being utilized across all continents, with two fifths (41%) noting the value for cross-organization collaboration and a third (32%) highlighting the benefits in international collaboration more broadly. With global scientific knowledge and resources spread across the world, over two fifths (41%) said community adoption of a workflow system was very important to the future of their research. One in three (34%) noted the financial savings that open-source scientific workflows had brought them as significant for their research.Harshil Patel, Head of Scientific Development, Seqera Labs comments: “Significant improvements in the ability for data orchestration tools to manage and organize large volumes of data empowered nations to monitor the spread of Covid-19 and continue to operate at the forefront of the world’s defences against the likes of influenza, RSV and Avian Flu. These tools are operating on the precipice of scientific discovery and are acting as the first line of defence against pandemic threats. Improved efficiency and scalability of research infrastructure is now fundamental for ongoing scientific research and future breakthroughs as they are no longer impeded by cost or capacity restraints when it comes to the pipelines used.”As breakthroughs in personalized medicines and gene therapies create the prospect of ever-more sophisticated treatments for patients, the scientific infrastructure behind such research is improving alongside it
Find jobs on Simplify and start your career today
Industries
Data & Analytics
Enterprise Software
Biotechnology
Healthcare
Company Size
51-200
Company Stage
Series A
Total Funding
$29.8M
Headquarters
Barcelona, Spain
Founded
2018
Find jobs on Simplify and start your career today